Light-Induced Therapies for Prostate Cancer Treatment
Open Access
- 29 October 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 7, 719
Abstract
Prostate cancer (PC) is one of the most widespread tumors affecting the urinary system and the fifth-leading cause from cancer death in men worldwide. Despite PC mortality rates have been decreasing during the last years, most likely due to an intensification of early diagnosis, still more than 300,000 men die each year because of this disease. In this view, researchers in all countries are engaged in finding new ways to tackle PC, including the design and synthesis of novel molecular and macromolecular entities able to challenge different PC biological targets, while limiting the extent of unwanted side effects that significantly limit men's life quality. Among this field of research, photo-induced therapies, such as photodynamic and photothermal therapies (PDT and PTT), might represent an important advancement in PC treatment due to their extremely localized and controlled cytotoxic effect, as well as their low incidence of side effects and tumor resistance occurrence. Based on these considerations, this review aims to gather and discuss the last 5-years literature reports dealing with the synthesis and biological activity of molecular conjugates and nano-platforms for photo-induced therapies as co-adjuvant or combined therapeutic modalities for the treatment of localized PC.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro
This publication has 105 references indexed in Scilit:
- Mechanistic study of IR-780 dye as a potential tumor targeting and drug delivery agentBiomaterials, 2014
- Mesenchymal stem cell: An efficient mass producer of exosomes for drug deliveryAdvanced Drug Delivery Reviews, 2013
- Dopamine‐Melanin Colloidal Nanospheres: An Efficient Near‐Infrared Photothermal Therapeutic Agent for In Vivo Cancer TherapyAdvanced Materials, 2012
- Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase InhibitorMolecular Cancer Therapeutics, 2012
- The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapyChemical Society Reviews, 2012
- Frontiers in cancer nanomedicine: directing mass transport through biological barriersTrends in Biotechnology, 2010
- Integrins in cancer: biological implications and therapeutic opportunitiesNature Reviews Cancer, 2010
- The polyamine transport system as a target for anticancer drug developmentAmino Acids, 2009
- Squalene: A natural triterpene for use in disease management and therapyAdvanced Drug Delivery Reviews, 2009
- Photodynamic Therapy in OncologyThe Oncologist, 2006